Genistein To Decrease Matrix Metalloproteinase-2 (Mmp-2) And Matrix Metalloproteinase-9 (Mmp-9) Levels In Peritoneal Fluid Of Endometriosis On Mice Model
Genistein administration decreased matrix metalloproteinase-2 and -9 levels in the peritoneal fluid of a mouse model of endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
The paper experimentally tested whether genistein reduces matrix metalloproteinases MMP-2 and MMP-9 in peritoneal fluid from a mouse model of endometriosis, using eight groups including negative/positive controls and genistein doses from 50 to 500 mg/day. MMP-2 and MMP-9 levels were quantified by ELISA, and results were analyzed with ANOVA, Tukey, and regression. Genistein decreased MMP-2 at the lowest doses reported (notably 50 mg/day and 100 mg/day, and also 400 mg/day among the lowest values) and decreased MMP-9 at 50–400 mg/day, with the lowest MMP-9 levels observed at 50 and 100 mg/day. The study’s main limitation explicitly acknowledged is that further work is needed in another animal model (the authors mention rabbits) to evaluate genistein’s effects beyond mice. This paper is centrally about endometriosis—genistein’s effect on MMP-2 and MMP-9 levels in peritoneal fluid in a mouse model of endometriosis.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
9,450 characters
· extracted from
oa-doi-fallback
· 7 sections
· click to expand
Abstract
Abstract
Method
Result
Conclusion
Keywords
Keywords
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (18)
- Biomarkers of Endometriosis via openalex
- Endometriosis: Diagnosis and Management via openalex
- Genistein causes regression of endometriotic implants in the rat model via openalex
- Increased expression of matrix metalloproteinase-9 in the eutopic endometrial tissue of women with endometriosis via openalex
- Matrix metalloproteinases 2 and 9, E-cadherin, and β-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium via openalex
- The effects of genistein on estrogen receptor expression, cell proliferation, and apoptosis in endometriosis cell culture via openalex
- The role of matrix metalloproteinases in the pathogenesis of endometriosis(literature review) via openalex
- W2163526156 via openalex
- W2289009903 via openalex
- W2793657505 via openalex
- W1994699011 via openalex
- W4253083734 via openalex
- W2015065898 via openalex
- W2032737777 via openalex
- W2080040408 via openalex
- W2082942776 via openalex
- W2093246348 via openalex
- W2153264091 via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00